The Innovative Medicines Initiative 2 (IMI2) has recently launched its 7th and 8th Call for proposals.
- Call 7 includes the topics of safety, neurological disorders, pain, eye diseases, cancer and big data.
- Call 8 includes Ebola and related diseases.
IMI is a joint activity between the European Union and the European Federation of Pharmaceutical Industry Association EFPIA. It launches a number of research and/or training projects every year as part of its aim of accelerating the development of better and safer medicines.
Project participants are recruited through open calls for research proposals, and the final selection of winning proposals is based on independent peer review. IMI is the EU's largest public-private initiative, with a total budget of €3.3 billion for the period 2014-2024.
Both Calls are now open for submission of Expressions of Interest. The Stage 1 submission deadline for Call 7 is 17 March 2016 at 17:00CET.
You can access the IMI2 Call 7 webpage here and the IMI2 Initiative homepage here